期刊文献+

综合干预对慢性阻塞性肺疾病稳定期的作用 被引量:3

Effect of comprehensive intervention on COPD patients in stable phase
下载PDF
导出
摘要 目的研究综合干预措施对慢性阻塞性肺疾病稳定期的作用。方法 COPD稳定期患者180名,随机分为三组,每组60名。分别于治疗前及治疗6个月记录肺功能、6分钟步行距离(6MWD)、生活质量评分、运动时最低氧饱和度、体重指数、肺动脉平均压。结果综合治疗组6MWD、生活质量评分、运动时最低氧饱和度、肺动脉平均压较中药治疗组及对照组有明显改善(P<0.05),具有统计学差异。而肺功能、体重指数的变化组间无统计学差异(P>0.05)。结论综合干预措施对COPD稳定期患者有积极作用。 Objective To explore the effect of comprehensive intervention on patients with COPD ( chronic obstructive pulmonm'y disease) in stable phase. Methods 180 COPD patients in stable phase were randomly divided into 3 groups evenly, and the following indexes were recorded and analyzed 6 months before and after the treatment: data of respiratory function, 6 minutes' walk distance (6MWD) , quality of life, lowest movement oxygen saturation, baric index and mean pulmonary artery pressure (MPA). Results There were significant differences in the improvement of 6 minutes'walk distance (6MWD), score of living quality, lowest movement oxygen saturation and MPA among the synthetical treatment group, the Chinese traditional medicine treatment group and the control group ( P 〈 0. 05 ), but there was no significant difference in the improvement of respiratory function and barie index among the three groups ( P 〉 0. 05 ). Conclusion Comprehensive intervention has a positive effect for the patients with COPD.
出处 《临床肺科杂志》 2012年第11期1960-1962,共3页 Journal of Clinical Pulmonary Medicine
基金 河北衡水市科技局资助项目(No 07015A)
关键词 综合干预 通肺合剂 阻塞性肺疾病稳定期 comprehensive intervention lung permeability mixture COPD stable phase
  • 相关文献

参考文献12

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1795
  • 2Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease [ J ]. N Engl J Med, 2008, 359 : 1543 - 1554.
  • 3Calverley P, et al. Trial of inhaled steroids and long-acting beta-ago- nists in COPD[J]. Lancet, 2003 ;361:449 -456.
  • 4Peter M A. Calverley, M D, Julie A. Anderson, et al. Salmetersol and Fluticasone Propionate and Survival in Chronic Obstructive Pul- monary Disease[ J]. N Engl J Med 2007 ;356:775 -789.
  • 5Singh D, Brooks J, Hagan G, et al. Superiority of " triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus indivdual components in moderate to severe COPD [ J ]. Thorax 2008 ;63 (7) :592 - 598.
  • 6Zheng JP, Kang J, Huang SG, et al. Effect of Carbocisteincon acute exacorbation of Chronic obstructive Pulmonary Disease[J]. Lancet, 2008 371(9629) :2013 -8. PMID:18555912.
  • 7Fabbri LM, Rabe KF. From COPD to Systemic Inflammatory Syn- drome[ J]. Lancet 2007 ;370:797 - 799.
  • 8Yang IA;Fong KM,Sim EH, et al. Inhaled corticosteroids for stable chronic obstructive pulmonary disease[ M ]. C-chrane Database Syst Rev 2007 ; (2) : CD002991.
  • 9崔朝勃,袁雅冬,刘淑红,韩东亮,高秀玲,齐富存.通肺合剂对慢性阻塞性肺疾病夜间低氧血症的干预作用[J].中国中西医结合杂志,2004,24(10):885-888. 被引量:3
  • 10孙增涛,刘恩顺,封继宏,付敏.补肺颗粒对COPD稳定期患者生活质量的影响[J].上海中医药杂志,2009,43(3):15-16. 被引量:9

二级参考文献28

共引文献1832

同被引文献17

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部